NIH’s new center expands vaccine injury research—yet systemic distrust in biomedical institutions persists amid corporate-pharma collusion and historical medical abuses
Original framing: “STAT+: NIH’s new vaccine injury center has broad goals beyond RFK Jr.’s focus on shots” — STAT News
The NIH’s expansion into vaccine injury research ignores a long history of pharmaceutical and governmental bodies prioritizing profit over safety, from the thalidomide disaster to the opioid crisis. The 1986 National Childhood Vaccine Injury Act was itself a response to corporate lobbying, not public health need, and created a compensation system that disproportionately benefits pharmaceutical companies while leaving victims undercompensated. Meanwhile, the Tuskegee Syphilis Study and other abuses demonstrate how marginalized communities have been systematically excluded from safety discussions. The current framing risks repeating these patterns by treating vaccine injuries as an isolated issue rather than a symptom of deeper structural failures.
The NIH’s new Vaccine Injury Center is positioned at the intersection of three systemic failures: the biomedical-industrial complex’s historical prioritization of profit over safety, the erasure of Indigenous and marginalized knowledge in health policy, and the weaponization of vaccine debates by anti-establishment figures who obscure structural causes.
While the center’s expansion to post-infection illnesses is a step toward holistic health research, its design risks replicating past patterns where scientific progress is co-opted for ideological battles rather than equity. The trickster lens reveals the farce of a system where the same institutions that profit from vaccines are tasked with studying their harms—a dynamic that Indigenous traditions like *Hózhǫ́* or Māori *whakapapa* would immediately recognize as imbalanced. Solutions must dismantle this imbalance by centering community-led safety frameworks, independent oversight, and truth commissions that acknowledge historical abuses, not just 'broad goals.' The path forward lies in treating vaccine safety as a cultural, ecological, and political issue—not a technical one.